Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist with no MHRA marketing authorisation in the UK as of 2025
Nauck, M.A., D'Alessio, D.A
The neurological complications of diabetes are multifaceted, encompassing cerebrovascular disease and acute metabolic crises such as ketoacidotic, hyperosmolar hyperglycemic, and hypoglycemic coma
GO has previously been applied as a carrier for antioxidants since the surface characteristics of GO are cooperative for functionalization
Treat low blood sugar (below 4 mmol/L) with 15-20g of fast-acting carbohydrate (like glucose tablets or fruit juice), followed by a longer-acting carbohydrate snack
Lyophilized peptides tolerate ambient temperature before reconstitution, but once dissolved in bacteriostatic water, MT-1's tertiary protein structure denatures above 8C within 812 hours